References:
1. Woo, P., Ng, B., Wong, J., Ng, O., Chan, T., Kwok, N. F., & Chan, K. Y. (2021). The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases. Chinese neurosurgical journal, 7(1), 13. https://doi.org/10.1186/s41016-021-00233-5
2. Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: A systematic review. Medicine (Baltimore). 2016 Jun;95(26): e4002. doi: 10.1097/MD.0000000000004002. PMID: 27368010; PMCID: PMC4937924.
3. Baptista B, Casian A, Gunawardena H, D’Cruz D, Rice CM. Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol. 2017 Apr;19(4):14. doi: 10.1007/s11940-017-0450-9. PMID: 28374231; PMCID: PMC5378735.
4. Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of IgG4-related disease. Frontline Gastroenterol. 2019 Jul;10(3):275-283. doi: 10.1136/flgastro-2018-101001. Epub 2018 Oct 31. PMID: 31288262; PMCID: PMC6583577.
5. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014 Jun;71(6):785-93. doi: 10.1001/jamaneurol.2014.243. PMID: 24733677.
6. Lin CK, Lai DM. IgG4-related intracranial hypertrophic pachymeningitis with skull hyperostosis: a case report. BMC Surg. 2013 Sep 21; 13:37. doi: 10.1186/1471-2482-13-37. PMID: 24053604; PMCID: PMC3856477.
7. Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013 Jul;92(4):206-216. doi: 10.1097/MD.0b013e31829cce35. PMID: 23793110; PMCID: PMC4553969.
8. Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009 Aug;33(8):1249-52. doi: 10.1097/PAS.0b013e3181abdfc2. PMID: 19561447.
9. Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review. Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4): e568. doi: 10.1212/NXI.0000000000000568. PMID: 31355304; PMCID: PMC6624094.
10. Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010 Dec;120(6):765-76. doi: 10.1007/s00401-010-0746-2. Epub 2010 Sep 16. PMID: 20844883
11. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4- related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22:21–30
12. Wang L, Chu X, Ma Y, Zhang M, Wang X, Jin L, Tan Z, Li X, Li X. A Comparative Analysis of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders. Am J Med Sci. 2017 Sep;354(3):252-256. doi: 10.1016/j.amjms.2017.05.009. Epub 2017 May 24. PMID: 28918831.
13. Della-Torre E, Galli L, Franciotta D, Bozzolo EP, Briani C, Furlan R, Roveri L, Sessa M, Passerini G, Sabbadini MG. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. J Neuroimmunol. 2014 Jan 15;266(1-2):82-6. doi: 10.1016/j.jneuroim.2013.10.008. Epub 2013 Oct 22. PMID: 24289956.
14. Miyazaki H, Tabuse M, Ishiyama N, Kikuchi R, Ogihara T, Nanki K. A case of multifocal fibrosclerosis presenting with chronic subdural hematoma. Brain and Nerve. 2011; 63:795 –9. 8. He Z, Ding F, Rong J, Gan Y.
15. A case of idiopathic hypertrophic cranial pachymeningitis presenting as chronic subdural hematoma. J Zhejiang Univ (Med Sci). 2016; 45:540 –3.
16. Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report Kazumichi Ota*, Yoshihiko Nakazato, Risa Okuda, Ryu Yokoyama, Hitoshi Kawasaki, Naotoshi Tamura and Toshimasa Yamamoto
17.Park IS, Kim H, Chung EY, Cho KW. Idiopathic hypertrophic cranial pachymeningitis misdiagnosed as acute subtentorial hematoma. Journal of Korean Neurosurgical Society. 2010 Aug;48(2):181-184. DOI: 10.3340/jkns.2010.48.2.181.
18. Lee YS, Lee HW, Park KS, Park SH, Hwang JH (2014) Immunoglobulin g4-related hypertrophic pachymeningitis with skull involvement. Brain Tumor Res Treat 2(2):87–91.
19. Raj R. IgG4-related lung disease. Am J Respir Crit Care Med. 2013 Sep 1;188(5):527-9. doi: 10.1164/rccm.201306-1121ED. PMID: 23992587.
20.Wyrostek S, Chakrabarti S, Baldwin K, Avila JD. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA. Case Rep Neurol. 2019 Oct 28;11(3):290-294. doi: 10.1159/000502569. PMID: 31762760; PMCID: PMC6872998.
21. Wallace ZS, Mattoo H, Mahajan VS, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford) 2016; 55:1000–1008.
22. Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PLoS One 2017;12: e0183844. 29. Carruthers MN, Topazian MD, Khosroshahi A, et al.
23.Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015; 74:1171–1177.